SEALSQ (LAES) had the highest return between December 27, 2023 and January 10, 2024 by a small-cap US stock, returning 74.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
SEALSQ (LAES) | 12/27/2023 - 1/10/2024 | 74.11% |
Sana Biotechnology (SANA) | 12/27/2023 - 1/10/2024 | 55.41% |
ATAI Life Sciences (ATAI) | 12/27/2023 - 1/10/2024 | 51.84% |
Yirendai (YRD) | 12/27/2023 - 1/10/2024 | 48.68% |
Qilian International (BGM) | 12/27/2023 - 1/10/2024 | 44.58% |
Richtech Robotics Inc Class B Common Stock (RR) | 12/27/2023 - 1/10/2024 | 40.87% |
I-Mab (IMAB) | 12/27/2023 - 1/10/2024 | 40.25% |
Ardelyx (ARDX) | 12/27/2023 - 1/10/2024 | 39.05% |
Iovance Biotherapeutics (IOVA) | 12/27/2023 - 1/10/2024 | 32.44% |
ADC Therapeutics (ADCT) | 12/27/2023 - 1/10/2024 | 32.12% |
Bright Minds Biosciences (DRUG) | 12/27/2023 - 1/10/2024 | 30.67% |
Zepp Health (ZEPP) | 12/27/2023 - 1/10/2024 | 30.67% |
Akebia Ther (AKBA) | 12/27/2023 - 1/10/2024 | 30.58% |
Solid Biosciences LLC (SLDB) | 12/27/2023 - 1/10/2024 | 30.48% |
QuantaSing Group Limited American Depositary Shares (QSG) | 12/27/2023 - 1/10/2024 | 29.52% |
Here (HERE) | 12/27/2023 - 1/10/2024 | 29.52% |
Capital Clean Energy Carriers (CCEC) | 12/27/2023 - 1/10/2024 | 27.74% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 12/27/2023 - 1/10/2024 | 27.59% |
Corvus Pharmaceuticals (CRVS) | 12/27/2023 - 1/10/2024 | 27.59% |
Verastem (VSTM) | 12/27/2023 - 1/10/2024 | 26.42% |
Aeva Technologies, Inc Common Stock (AEVA) | 12/27/2023 - 1/10/2024 | 26% |
Enanta Pharmaceuticals (ENTA) | 12/27/2023 - 1/10/2024 | 25.55% |
Aquestive Therapeutics (AQST) | 12/27/2023 - 1/10/2024 | 25.49% |
Keros Therapeutics (KROS) | 12/27/2023 - 1/10/2024 | 24.76% |
Highest Performances (MAAS) | 12/27/2023 - 1/10/2024 | 24.64% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
